Global and United States Sumatriptan Succinate Market Insights, Forecast to 2026
1 Study Coverage
- 1.1 Sumatriptan Succinate Product Introduction
- 1.2 Market Segments
- 1.3 Key Sumatriptan Succinate Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Sumatriptan Succinate Market Size Growth Rate by Type
- 1.4.2 Tablet
- 1.4.3 Subcutaneous Injection
- 1.4.4 Nasal Spray
- 1.5 Market by Application
- 1.5.1 Global Sumatriptan Succinate Market Size Growth Rate by Application
- 1.5.2 Oral
- 1.5.3 Subcutaneous Injection
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Sumatriptan Succinate Market Size, Estimates and Forecasts
- 2.1.1 Global Sumatriptan Succinate Revenue 2015-2026
- 2.1.2 Global Sumatriptan Succinate Sales 2015-2026
- 2.2 Global Sumatriptan Succinate, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Sumatriptan Succinate Historical Market Size by Region (2015-2020)
- 2.3.1 Global Sumatriptan Succinate Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Sumatriptan Succinate Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Sumatriptan Succinate Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Sumatriptan Succinate Sales Forecast by Region (2021-2026)
- 2.4.2 Global Sumatriptan Succinate Revenue Forecast by Region (2021-2026)
3 Global Sumatriptan Succinate Competitor Landscape by Players
- 3.1 Global Top Sumatriptan Succinate Sales by Manufacturers
- 3.1.1 Global Sumatriptan Succinate Sales by Manufacturers (2015-2020)
- 3.1.2 Global Sumatriptan Succinate Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Sumatriptan Succinate Manufacturers by Revenue
- 3.2.1 Global Sumatriptan Succinate Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Sumatriptan Succinate Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Sumatriptan Succinate Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Sumatriptan Succinate Revenue in 2019
- 3.2.5 Global Sumatriptan Succinate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Sumatriptan Succinate Price by Manufacturers
- 3.4 Global Sumatriptan Succinate Manufacturing Base Distribution, Product Types
- 3.4.1 Sumatriptan Succinate Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Sumatriptan Succinate Product Type
- 3.4.3 Date of International Manufacturers Enter into Sumatriptan Succinate Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Sumatriptan Succinate Market Size by Type (2015-2020)
- 4.1.1 Global Sumatriptan Succinate Sales by Type (2015-2020)
- 4.1.2 Global Sumatriptan Succinate Revenue by Type (2015-2020)
- 4.1.3 Sumatriptan Succinate Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Sumatriptan Succinate Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Sumatriptan Succinate Sales Forecast by Type (2021-2026)
- 4.2.2 Global Sumatriptan Succinate Revenue Forecast by Type (2021-2026)
- 4.2.3 Sumatriptan Succinate Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Sumatriptan Succinate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Sumatriptan Succinate Market Size by Application (2015-2020)
- 5.1.1 Global Sumatriptan Succinate Sales by Application (2015-2020)
- 5.1.2 Global Sumatriptan Succinate Revenue by Application (2015-2020)
- 5.1.3 Sumatriptan Succinate Price by Application (2015-2020)
- 5.2 Sumatriptan Succinate Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Sumatriptan Succinate Sales Forecast by Application (2021-2026)
- 5.2.2 Global Sumatriptan Succinate Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Sumatriptan Succinate Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
- 6.1 United States Sumatriptan Succinate Market Size YoY Growth 2015-2026
- 6.1.1 United States Sumatriptan Succinate Sales YoY Growth 2015-2026
- 6.1.2 United States Sumatriptan Succinate Revenue YoY Growth 2015-2026
- 6.1.3 United States Sumatriptan Succinate Market Share in Global Market 2015-2026
- 6.2 United States Sumatriptan Succinate Market Size by Players (International and Local Players)
- 6.2.1 United States Top Sumatriptan Succinate Players by Sales (2015-2020)
- 6.2.2 United States Top Sumatriptan Succinate Players by Revenue (2015-2020)
- 6.3 United States Sumatriptan Succinate Historic Market Review by Type (2015-2020)
- 6.3.1 United States Sumatriptan Succinate Sales Market Share by Type (2015-2020)
- 6.3.2 United States Sumatriptan Succinate Revenue Market Share by Type (2015-2020)
- 6.3.3 United States Sumatriptan Succinate Price by Type (2015-2020)
- 6.4 United States Sumatriptan Succinate Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 United States Sumatriptan Succinate Sales Forecast by Type (2021-2026)
- 6.4.2 United States Sumatriptan Succinate Revenue Forecast by Type (2021-2026)
- 6.4.3 United States Sumatriptan Succinate Price Forecast by Type (2021-2026)
- 6.5 United States Sumatriptan Succinate Historic Market Review by Application (2015-2020)
- 6.5.1 United States Sumatriptan Succinate Sales Market Share by Application (2015-2020)
- 6.5.2 United States Sumatriptan Succinate Revenue Market Share by Application (2015-2020)
- 6.5.3 United States Sumatriptan Succinate Price by Application (2015-2020)
- 6.6 United States Sumatriptan Succinate Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 United States Sumatriptan Succinate Sales Forecast by Application (2021-2026)
- 6.6.2 United States Sumatriptan Succinate Revenue Forecast by Application (2021-2026)
- 6.6.3 United States Sumatriptan Succinate Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Sumatriptan Succinate Market Size YoY Growth 2015-2026
- 7.2 North America Sumatriptan Succinate Market Facts & Figures by Country
- 7.2.1 North America Sumatriptan Succinate Sales by Country (2015-2020)
- 7.2.2 North America Sumatriptan Succinate Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Sumatriptan Succinate Market Size YoY Growth 2015-2026
- 8.2 Europe Sumatriptan Succinate Market Facts & Figures by Country
- 8.2.1 Europe Sumatriptan Succinate Sales by Country
- 8.2.2 Europe Sumatriptan Succinate Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Sumatriptan Succinate Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Sumatriptan Succinate Market Facts & Figures by Country
- 9.2.1 Asia Pacific Sumatriptan Succinate Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Sumatriptan Succinate Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Sumatriptan Succinate Market Size YoY Growth 2015-2026
- 10.2 Latin America Sumatriptan Succinate Market Facts & Figures by Country
- 10.2.1 Latin America Sumatriptan Succinate Sales by Country
- 10.2.2 Latin America Sumatriptan Succinate Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Sumatriptan Succinate Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Sumatriptan Succinate Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Sumatriptan Succinate Sales by Country
- 11.2.2 Middle East and Africa Sumatriptan Succinate Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 GlaxoSmithKline
- 12.1.1 GlaxoSmithKline Corporation Information
- 12.1.2 GlaxoSmithKline Description and Business Overview
- 12.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 GlaxoSmithKline Sumatriptan Succinate Products Offered
- 12.1.5 GlaxoSmithKline Recent Development
- 12.2 Imitrex
- 12.2.1 Imitrex Corporation Information
- 12.2.2 Imitrex Description and Business Overview
- 12.2.3 Imitrex Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Imitrex Sumatriptan Succinate Products Offered
- 12.2.5 Imitrex Recent Development
- 12.3 Teva
- 12.3.1 Teva Corporation Information
- 12.3.2 Teva Description and Business Overview
- 12.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Teva Sumatriptan Succinate Products Offered
- 12.3.5 Teva Recent Development
- 12.4 Sandoz
- 12.4.1 Sandoz Corporation Information
- 12.4.2 Sandoz Description and Business Overview
- 12.4.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Sandoz Sumatriptan Succinate Products Offered
- 12.4.5 Sandoz Recent Development
- 12.5 Mylan
- 12.5.1 Mylan Corporation Information
- 12.5.2 Mylan Description and Business Overview
- 12.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Mylan Sumatriptan Succinate Products Offered
- 12.5.5 Mylan Recent Development
- 12.6 Roxane Pa
- 12.6.1 Roxane Pa Corporation Information
- 12.6.2 Roxane Pa Description and Business Overview
- 12.6.3 Roxane Pa Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Roxane Pa Sumatriptan Succinate Products Offered
- 12.6.5 Roxane Pa Recent Development
- 12.7 Dabur Pharmaceuticals
- 12.7.1 Dabur Pharmaceuticals Corporation Information
- 12.7.2 Dabur Pharmaceuticals Description and Business Overview
- 12.7.3 Dabur Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Dabur Pharmaceuticals Sumatriptan Succinate Products Offered
- 12.7.5 Dabur Pharmaceuticals Recent Development
- 12.8 Sun Pharmaceutical
- 12.8.1 Sun Pharmaceutical Corporation Information
- 12.8.2 Sun Pharmaceutical Description and Business Overview
- 12.8.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Sun Pharmaceutical Sumatriptan Succinate Products Offered
- 12.8.5 Sun Pharmaceutical Recent Development
- 12.11 GlaxoSmithKline
- 12.11.1 GlaxoSmithKline Corporation Information
- 12.11.2 GlaxoSmithKline Description and Business Overview
- 12.11.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 GlaxoSmithKline Sumatriptan Succinate Products Offered
- 12.11.5 GlaxoSmithKline Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Sumatriptan Succinate Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Sumatriptan Succinate Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Sumatriptan Succinate market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Sumatriptan Succinate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Sumatriptan Succinate market is segmented into
Tablet
Subcutaneous Injection
Nasal Spray
Segment by Application, the Sumatriptan Succinate market is segmented into
Oral
Subcutaneous Injection
Regional and Country-level Analysis
The Sumatriptan Succinate market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sumatriptan Succinate market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Sumatriptan Succinate Market Share Analysis
Sumatriptan Succinate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sumatriptan Succinate business, the date to enter into the Sumatriptan Succinate market, Sumatriptan Succinate product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Imitrex
Teva
Sandoz
Mylan
Roxane Pa
Dabur Pharmaceuticals
Sun Pharmaceutical